| abstract |
FIELD: biotechnology and immunology. n SUBSTANCE: invention relates to biotechnology and immunology. A gene is proposed that allows the production of an artificial protein with immunogenic properties against SARS-CoV-2, a plasmid containing it, as well as the artificial protein itself, obtained using an E. coli cell line modified by the described plasmid. n EFFECT: resulting recombinant protein has immunogenic properties against SARS-CoV-2 and can be used as an active substance for obtaining a vaccine against SARS-CoV-2. n 5 cl, 3 dwg, 4 tbl, 6 ex |